Complete Health Store
Complete Health Store

                              Health Talk Blog

                                               U.S.                                                            California

                                  CASES               DEATHS                             CASES                  DEATHS       

December 2020    19,111,443        341,149                     2,120,610             24,241

 

2021   Timeline

January              26,185,362        441,319                     3,310,949             40,702

February            28,602,101        513,137                     3,563,578             51,953

 

UPDATED WEEKLY - Last updated on 1 March, 2021 9:30 am PST, John Hopkins Corona Virus Dashboard and Worldometer

Cases Worldwide

                       John Hopkins                                                    Worldometer

  • TOTAL CASES    -  114,240,823                     TOTAL CASES        -   114,822,842

  Recovered     -   64,494,855                         Recovered         -     90,407,492

  • TOTAL DEATHS  -    2,533,323                     TOTAL DEATHS      -      2,545,435

 

Cases in the U.S.

POPULATION - is 330,087,304 as of 15 February 2021, 9:25 am PST, based on Census U.S. and World Population Clock.

  • TOTAL CASES    -  28,609,645                     TOTAL CASES        -     29,259,160

 Recovered      -                                        Recovered          -     19,694,344

  • TOTAL DEATHS  -      513,137                     TOTAL DEATHS      -         525,808

 

The current U.S. unemployment rate is 6.7% for January 2021, the Bureau of Labor Statistics (BLS) said in its monthly report, released February 5, 2021. The rate is close to double the 3.5% rate in February 2020, before the COVID-19 pandemic.

 

Cases in California

  • TOTAL CASES    -   3,566,914                     TOTAL CASES         -      3,555,010

Recovered       -                                       Recovered           -      1,849,634

  • TOTAL DEATHS  -       52,158                     TOTAL DEATHS      -           52,213

 

December 2020 Unemployment numbers were 1,700,383 or 9%.      

 

03/1/2021                 Cases (WHO)                   Deaths (WHO)               Recovered (WHO)

  • Texas          -   2,657,614                     44,072                       2,434,004
  • Florida**      -   1,909,221                      30,853                      1,121,594
  • New York      -   1,680,688                     47,827                         745,551
  • Illinois         -   1,186,696                     22,735                       1,085,984
  • Georgia**     -   1,006,521                     17,295                         488,686
  • Ohio            -     967,422                     17,299                         909,524
  • Pennsylvania -     936,614                     24,121                         836,727
  • N. Carolina** -    858,548                     11,212                         795,521
  • Arizona **   -   816,782                    15,980                       114,855
  • Tennessee    -     775,004                     11,411                        749,863

 

*correction

          **reporting information is limited, reduced testing and increased cases

 

 

 

MARCH BLOG

 

MARCH BLOG

COVID 19 UPDATE

 

Vaccine Update - Coronavirus Vaccine Tracker

By Carl Zimmer, Jonathan Corum and Sui-Lee Wee, Updated 28 February, 2021

    

       PHASE 1            PHASE 2              PHASE 3             AUTHORIZED       APPROVED7

            40                       27                        20                               6                          4

     Vaccines          Vaccines           Vaccines               Vaccines          Vaccines

   testing safety   in expanded       in large scale          in early or        approved

    and dosage      safety trials      efficacy tests        or limited use      full use

 

  • 28 Jan – Johnson & Johnson reports lower efficacy data in South Africa.
  •   2 Feb - Russia’s Sputnik V vaccine has an efficacy of 91.6%.
  •   3 Feb – Mexico authorizes Russia’s Sputnik V vaccine
  •   7 Feb – South Africa halts plans for a rollout of AstraZeneca’s vaccine.

 

HOUSE PASSES $1.9 TRILLION COVID RELIEF BILL.  The House voted early Saturday to pass President Biden's $1.9 trillion Covid-19 relief package, a step to implement bringing the pandemic under control, days after the U.S. crossed the milestone of 500,000 deaths.

 

The House voted to approve the bill, which includes $1,400 direct payments, a $400-a-week federal unemployment bonus, a per-child allowance of up to $3,600 for one year and billions of dollars to distribute the coronavirus vaccines and to assist schools and local governments.

Polls show the package is popular with most Americans, earning 66 percent support in an Economist/YouGov study and 76 percent support in a Morning Consult/Politico survey.

 

VACCINE STATISTICS.  According to Our Word Data, as of 27 February, the United States has vaccinated 72.81 million reaching 14.6% of the total U.S. population and data collected by the Centers for Disease Control and Prevention.  Approximate totals of the vaccine distribution as of 26 February:  Pfizer - 36.16 million and Moderna – 34.18 million doses.  The U.S. currently is administering over 1.6 million shots a day.

 

Note:  This is calculated as a single dose and may not equal the total number of people vaccinated, depending on the specific dose regime.  If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1, if they receive the second dose, the metric stays the same.

 

                                    Single dose               2nd Dose

  • Arizona                 16.8%                     6.8%
  • California              15.2%                     6.3%
  • Florida                  14.4%                     7.9%
  • New York               13.3%                     7.1%
  • Texas                    12.4%                    6.2%

 

Vaccine Update.  Vaccine advisers to the US Centers for Disease Control and Prevention unanimously voted Sunday, 28 February, the distribution of a third vaccine for Americans 18 and older:  the one-dose, Johnson & Johnson vaccine.

 

The Johnson & Johnson vaccine uses a weakened live pathogen, adenovirus, as the delivery method or vector for transporting a recombinant vaccine for COVID-19.  The Johnson & Johnson vaccine can be kept at normal refrigerator temperatures for three months, something that committee members said would make it easy to distribute and administer.

 

The efficacy against moderate to severe COVID-19 infection varied by region in the trial, 72% in the United States, 66% in Latin America and 57% in South Africa.  The vaccine was also found to be fully protective against hospitalization and death and protection against severe disease, included multiple variants of COVID-19, including the B.1.351 variant found in South Africa.

 

Approximately 4 million doses of the Johnson & Johnson vaccine will be distributed across all channels, states, tribes, territories, pharmacies and community health centers," an official said in a briefing call Sunday night.  "Those doses will be delivered as early as this Tuesday morning."  Senior administration officials also cautioned that the amount of vaccine made available will be uneven throughout the month of March.

 

For the first time, since early November, fewer than 50,000 patients were hospitalized with Covid-19.  With that, there's been a decrease in new cases and deaths since the January surge.  Dr. Anthony Fauci advises that people should continue to take the vaccine they were initially vaccinated with – if initially vaccinated with the Pfizer vaccine, the second dose should be Pfizer.  He also warns some Americans are easing up on safety measures too soon -- threatening the same post-dip surges we suffered in 2020.

 

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

The FDA, has not approved but has authorized for emergency use, bamlanivimab and etesevimab, administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients - 12 years of age or older weighing at least 88 pounds, who test positive for SARS-CoV-2 and are at high risk for progressing to severe COVID-19.  The authorized use includes treatment for those who are 65 years of age or older or who have certain chronic medical conditions.

 

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses.  Bamlanivimab and etesevimab, monoclonal antibodies, are specifically directed against the spike protein of SARS-CoV-2.  The antibody combination is designed to block the virus’s attachment and entry into human cells and also bind to different overlapping sites on the spike protein of the virus.

 

Note:  In a clinical trial a single intravenous infusion significantly reduced COVID-19-related hospitalization and death during 29 days of follow-up compared to placebo.  Bamlanivimab and etesevimab are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19.  

 

Antibody treatments don’t contain any live SARS-CoV-2 and no risk you’ll get COVID-19. However, antibody treatment may have side effects:

 

  • Allergic reactions - can occur during and after an antibody infusion.  Contact your healthcare provider right away if you get any of the following signs and symptoms of allergic reactions:

 

  1. Fever,
  2. Chills,
  3. Nausea,
  4. Headache,
  5. Shortness of breath,
  6. Low blood pressure,
  7. Wheezing,
  8. Swelling of your lips, face, or throat,
  9. Rash, including hives and itching,
  10. Muscle aches,
  11. Dizziness.

 

Serious and unexpected side effects may happen. Some possible risks from antibody treatment are:

  • It may interfere with the body's ability to fight off a future infection of SARS-CoV-2
  • It may reduce your body’s immune response to a vaccine for SARS-CoV2

 

mAb treatments for COVID-19, like other treatments authorized for emergency use are still being studied. 

 

What Level of Herd Immunity Is Necessary?  Do we need 70% of the country to have been immunized?  Or as Dr. Fauci has recently said, is the figure closer to 80 – 85%?   In doing the calculation, do you include the 26 million Americans who have already had coronavirus infections? What about young people? 

 

The calculator below will allow you to figure out when immunity might be achieved at various immunization rates.

 

  • Shots administered per day nationally:  1.5 million
  • Herd immunity achieved at:  80 percent
  • Doses required: 
  • Vaccinate those already infected? 

 

At this rate, the country would reach 80 percent herd immunity through vaccinations by Dec. 24

 

With a population of approximately 330 million, means we would need 264 million to be resistant to the virus to hit 80 percent immunity.  We can take out the 5.8 million Americans already been vaccinated, leaving 244.3 million to be vaccinated.  From there the math is straightforward: doing two-shot vaccinations at a rate of 1.5 million shots per day means it will take 326 days to complete the job!

 

WHAT CAN WE DO?   There's no vaccine against the coronavirus, yet!   However, we repeat, you can take basic precautions to reduce your family's risk of getting this and other illnesses by:

 

  • Getting recommended vaccines on schedule
  • Avoiding close contact with sick people and staying home when sick
  • Not touching the eyes, nose, or mouth with unwashed hands
  • Coughing and sneezing into a tissue, and throwing the tissue in the trash

 

Stay safe.  Mask.  Social distance.  Frequent hand washing.  Avoid crowds.

 

ALWAYS CONSULT YOUR PERSONAL HEALTH CARE PROFESSIONAL

 

 

Write a comment

Comments

  • Barbra Rose Meyer (Tuesday, January 10 17 06:52 pm EST)

    Great blog! I left my position in brilliant hands! Very Informational!

  • Joe Felix (Sunday, December 03 17 07:06 pm EST)

    I found your COPD comments interesting. Would you consider doing a leaky gut syndrome segment?

Please enter the code
* Required fields

Store Location

Complete Health Store


1756 N. Riverside Ave
Rialto, CA 92376

Phone: 909 879-1059
Fax     : 909 879-1043

 

E-mail: completehealth@mail.com

Store Hours

Monday       10 am - 4:00 pm Tuesday       10 am - 4:00 pm

Wednesday  10 am - 4:00 pm

Thursday     10 am - 4:00 pm

Friday         10 am - 4:00 pm

Saturday     10 am - 3 pm

Sunday              CLOSED

 

**COVID-19 MODIFIED HOURS**

HOLIDAY HOURS MAY VARY

 

D'Lightful Bites

10:30 am - 3 pm

 

Phone orders are encouraged.

 

Deliveries available for orders $35.00 and over

Ongoing Sales!!!

Stop in to check out all the items currently discounted for your personal resolutions.

 

 

Get Social with Us

Print Print | Sitemap Recommend this page Recommend this page
© Complete Health Store